These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 210375

  • 21. [Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate].
    Mertz DP.
    Fortschr Med; 1980 Dec 04; 98(45):1761-6. PubMed ID: 7461569
    [Abstract] [Full Text] [Related]

  • 22. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
    Rouffy J, Dreux C, Goussault Y, Dakkak R, Renson FJ.
    Arzneimittelforschung; 1976 Dec 04; 26(5):901-6. PubMed ID: 183788
    [Abstract] [Full Text] [Related]

  • 23. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
    Bertolini S, Donati C, Elicio N, Daga A, Cuzzolaro S, Marcenaro A, Saturnino M, Balestreri R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov 04; 24(11):630-7. PubMed ID: 3098691
    [Abstract] [Full Text] [Related]

  • 24. Hypercholesterolemia in ExHC rats and lipid-lowering drug: a screening method for new hypocholesterolemic agents.
    Kitazaki T, Tsuda M, Matsumura H, Ohtagaki T, Imai Y.
    Artery; 1981 Nov 04; 9(6):414-24. PubMed ID: 6802106
    [Abstract] [Full Text] [Related]

  • 25. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P, Weisweiler P, Neureuther G.
    Artery; 1979 Feb 04; 5(2):117-24. PubMed ID: 231950
    [Abstract] [Full Text] [Related]

  • 26. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ, Linden CV, O'Connell MJ, Heilman J.
    Arch Intern Med; 1982 Apr 04; 142(4):721-3. PubMed ID: 7073415
    [Abstract] [Full Text] [Related]

  • 27. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R.
    Artery; 1979 Feb 04; 5(2):125-43. PubMed ID: 231951
    [Abstract] [Full Text] [Related]

  • 28. Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
    Shinomiya M, Ishikawa Y, Shirai K, Saito Y, Yoshida S.
    Arzneimittelforschung; 1987 Sep 04; 37(9):1069-71. PubMed ID: 3435604
    [Abstract] [Full Text] [Related]

  • 29. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Sep 04; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 30. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar 04; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of primary hyperlipoproteinemia type IIa and IIb with dextrothyroxine (author's transl)].
    Koschinsky T, Vogelberg KH, Gries FA.
    Dtsch Med Wochenschr; 1974 Mar 15; 99(11):494-6. PubMed ID: 4365046
    [No Abstract] [Full Text] [Related]

  • 32. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Chiesa G, Sirtori CR.
    J Lab Clin Med; 1989 Sep 15; 114(3):250-9. PubMed ID: 2504855
    [Abstract] [Full Text] [Related]

  • 33. [The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)].
    Mertz DP, Loewer H, Suermann I.
    Med Klin; 1979 Dec 21; 74(51-52):1953-6. PubMed ID: 542179
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
    Vorberg G, Ziegler WJ.
    Arzneimittelforschung; 1980 Dec 21; 30(11b):2068-72. PubMed ID: 7194062
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
    Schwartzkopff W, Schilling A, Calder D.
    Med Welt; 1980 Apr 04; 31(14):515-20. PubMed ID: 7374415
    [No Abstract] [Full Text] [Related]

  • 38. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG, Hutt V, Klör HU, Ditschuneit H.
    Artery; 1980 Apr 04; 8(6):519-29. PubMed ID: 7259531
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH.
    Dtsch Med Wochenschr; 1976 Dec 17; 101(51):1868-71. PubMed ID: 1001205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.